These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33608854)

  • 1. Gated SPECT left ventricular shape and prediction of super responders to cardiac resynchronization therapy: Not so easy as it (LV) looks.
    Altawil M; Greenberg J; Ananthasubramaniam K
    J Nucl Cardiol; 2022 Aug; 29(4):1547-1551. PubMed ID: 33608854
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular scar impact on left ventricular synchronization parameters and outcomes of cardiac resynchronization therapy.
    Ahmed W; Samy W; Tayeh O; Behairy N; Abd El Fattah A
    Int J Cardiol; 2016 Nov; 222():665-670. PubMed ID: 27517660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol.
    Friehling M; Chen J; Saba S; Bazaz R; Schwartzman D; Adelstein EC; Garcia E; Follansbee W; Soman P
    Circ Cardiovasc Imaging; 2011 Sep; 4(5):532-9. PubMed ID: 21772007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental value of left ventricular shape parameters measured by gated SPECT MPI in predicting the super-response to CRT.
    He Z; de Amorim Fernandes F; do Nascimento EA; Garcia EV; Mesquita CT; Zhou W
    J Nucl Cardiol; 2022 Aug; 29(4):1537-1546. PubMed ID: 33506382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Resynchronization Therapy for Improving Non-Uniform Thickening of Left Ventricular Wall: Assessment by Quantitative Gated Myocardial Perfusion SPECT.
    Wakayama Y; Nakano M; Fukuda K; Kumagai K; Sugai Y; Hirose M; Yamaguchi N; Kondo M; Kaneta T; Fukuda H; Kagaya Y; Shimokawa H
    Tohoku J Exp Med; 2020 Jun; 251(2):69-79. PubMed ID: 32493869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D and 2D left ventricular systolic function imaging-- from ejection fraction to deformation. Cardiac resynchronization therapy--substudy.
    Szulik M; Śliwińska A; Lenarczyk R; Szymała M; Kalinowski ME; Markowicz-Pawlus E; Kalarus Z; Kukulski T
    Acta Cardiol; 2015 Feb; 70(1):21-30. PubMed ID: 26137800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal left ventricular lead placement for cardiac resynchronization therapy in postmyocardial infarction patients.
    Muto C; Solimene F; Russo V; Nigro G; Rago A; Chianese R; Chiariello P; Ciardiello C; Caliendo L
    Future Cardiol; 2018 May; 14(3):215-224. PubMed ID: 29767542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy.
    Dreger H; Borges AC; Baumann G; Melzer C
    Cardiovasc Ultrasound; 2010 Sep; 8():35. PubMed ID: 20809960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.
    Mitro P; Murin P; Valocik G; Simurda M
    Cardiol J; 2014; 21(5):524-31. PubMed ID: 24526506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular-only pacing in heart failure patients with normal atrioventricular conduction improves global function and left ventricular regional mechanics compared with biventricular pacing: an adaptive cardiac resynchronization therapy sub-study.
    Burns KV; Gage RM; Curtin AE; Gorcsan J; Bank AJ
    Eur J Heart Fail; 2017 Oct; 19(10):1335-1343. PubMed ID: 28653458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research of predictive factors for cardiac resynchronization therapy: a prospective study comparing data from phase-analysis of gated myocardial perfusion single-photon computed tomography and echocardiography : Trying to anticipate response to CRT.
    Gendre R; Lairez O; Mondoly P; Duparc A; Carrié D; Galinier M; Berry I; Cognet T
    Ann Nucl Med; 2017 Apr; 31(3):218-226. PubMed ID: 28197975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective prediction of response to cardiac resynchronization therapy using a novel program of gated myocardial perfusion single photon emission computed tomography.
    Nakamura K; Takami M; Shimabukuro M; Maesato A; Chinen I; Ishigaki S; Higa S; Keida T; Masuzaki H
    Europace; 2011 Dec; 13(12):1731-7. PubMed ID: 21873328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy.
    Mesquita CT; Peix A; de Amorim Fernandes F; Giubbini R; Karthikeyan G; Massardo T; Patel C; Pabon LM; Jimenez-Heffernan A; Alexanderson E; Butt S; Kumar A; Marin V; Morozova O; Paez D; Garcia EV
    J Nucl Cardiol; 2022 Jun; 29(3):1166-1174. PubMed ID: 33152098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing.
    Schiedat F; Schöne D; Aweimer A; Bösche L; Ewers A; Gotzmann M; Patsalis PC; Mügge A; Kloppe A
    Clin Res Cardiol; 2020 Feb; 109(2):183-193. PubMed ID: 31152199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Resynchronization Therapy Response Assessment with Electromechanical Activation Mapping within 24 Hours of Device Implantation: A Pilot Study.
    Melki L; Wang DY; Grubb CS; Weber R; Biviano A; Wan EY; Garan H; Konofagou EE
    J Am Soc Echocardiogr; 2021 Jul; 34(7):757-766.e8. PubMed ID: 33675941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular regional remodeling and lead position during cardiac resynchronization therapy.
    Kronborg MB; Sommer A; Fyenbo DB; Norgaard BL; Gerdes C; Jensen JM; Jensen HK; Kristensen J; Nielsen JC
    Heart Rhythm; 2018 Oct; 15(10):1542-1549. PubMed ID: 29678780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre.
    Steffel J; Milosevic G; Hürlimann A; Krasniqi N; Namdar M; Ruschitzka F; Lüscher TF; Duru F; Holzmeister J; Hürlimann D
    Heart; 2011 Oct; 97(20):1668-74. PubMed ID: 21821856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for cardiac resynchronization therapy response: the importance of QRS morphology and left ventricular lead position.
    Lin H; Zhou Y; Xu G
    Int Heart J; 2014; 55(3):256-63. PubMed ID: 24806381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.